Shanghai's Ruijin Hospital has announced the open sourcing of the core visual basic model and accompanying test datasets within its RuiPath pathology model. This model encompasses seven prevalent cancer types, including lung and colorectal cancer, and addresses the diagnostic and treatment requirements for 90% of common cancers in China annually. Leveraging Huawei's DCS AI solution, Ruijin Hospital has also simultaneously launched the RuiPath Pathology Large Model Global Multicenter Program, with the objective of fostering international collaboration and advancement in medical AI technology.